Cargando…
The Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitor NVP-BHG712: Effects of Regioisomers on Tumor Growth, Perfusion, and Hypoxia in EphB4-Positive A375 Melanoma Xenografts
In a previous study, EphB4 was demonstrated to be a positive regulator of A375-melanoma growth but a negative regulator of tumor vascularization and perfusion. To distinguish between EphB4 forward and ephrinB2 reverse signaling, we used the commercially available EphB4 kinase inhibitor NVP-BHG712 (N...
Autores principales: | Neuber, Christin, Tröster, Alix, Löser, Reik, Belter, Birgit, Schwalbe, Harald, Pietzsch, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662635/ https://www.ncbi.nlm.nih.gov/pubmed/33153234 http://dx.doi.org/10.3390/molecules25215115 |
Ejemplares similares
-
The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis
por: Martiny-Baron, Georg, et al.
Publicado: (2010) -
Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments (‡)
por: Neuber, Christin, et al.
Publicado: (2018) -
The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study
por: Kathawala, Rishil J., et al.
Publicado: (2014) -
Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion
por: Lee, Tae Ho, et al.
Publicado: (2021) -
Radiopharmacologist’s and Radiochemist’s
View on Targeting the Eph/Ephrin Receptor Tyrosine Kinase System
por: Neuber, Christin, et al.
Publicado: (2020)